Utilizing High-Throughput Screening of dHL-60 Inflammatory Behaviors to Evaluate Honey-Derived Molecules' Potential as Immunomodulatory Biomaterial Additives.

However, an interesting trend was observed when individual experiment replicates were analyzed.

also in 1,024 other papers

At 3 hours post-stimulus, a therapeutic range of 600 μM to 2 mM methyl syringate reduced dHL60 NET release by more than 50%, except for the 800 μM dataset, which did not reach statistical significance ( Figure 6a ).

also in 75,281 other papers